CVE-2026-42933 — CRITICAL (10.0)

Vulnerability Description

Pronetiqs IntraVUE versions 3.2.1a14 and prior have an unintended proxy or intermediary vulnerability which could allow an attacker to use an active proxy, which would bypass OT segmentation.

CVSS Score

10.0

CRITICAL

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:C/C:H/I:H/A:H

Attack Vector

NETWORK

Attack Complexity

LOW

Privileges Required

NONE

User Interaction

NONE

Scope

CHANGED

Confidentiality

HIGH

Integrity

HIGH

Availability

HIGH

Related Weaknesses (CWE)

CWE-441

References

https://www.cisa.gov/news-events/ics-advisories/icsa-26-204-04

FAQ

What is CVE-2026-42933?

CVE-2026-42933 is a vulnerability with a CVSS score of 10.0 (CRITICAL). Pronetiqs IntraVUE versions 3.2.1a14 and prior have an unintended proxy or intermediary vulnerability which could allow an attacker to use an active proxy, which would bypass OT segmentation.

How severe is CVE-2026-42933?

CVE-2026-42933 has been rated CRITICAL with a CVSS base score of 10.0/10. This is considered a critical vulnerability requiring immediate attention.

Is there a patch for CVE-2026-42933?

Check the references section above for vendor advisories and patch information. Review vendor security bulletins for remediation guidance.